Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Aspect Biosystems logo — Developing Bioprinted Tissue Therapeutics to transform how w...

Aspect Biosystems

Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusive diseases.

Founded 2013 Canada Canada 143 employees Total: $323.73M Biotechnology, Life Sciences

General Information

Company Name Aspect Biosystems
Founded Year 2013
Location Canada Canada
Employees 143
Industries Biotechnology, Life Sciences
Business Model B2B, Platform
Revenue Model Licensing, Product Sales, Performance Based
Social

BounceWatch is an independent company data service, not affiliated with Aspect Biosystems. To contact Aspect Biosystems, visit aspectbiosystems.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Aspect Biosystems compare?

A PDF of Aspect Biosystems and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Aspect Biosystems soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Aspect Biosystems

Aspect Biosystems is a pioneering force in the biotechnology landscape, focusing on bioprinted tissue therapeutics that promise to transform treatments for particularly elusive diseases. Their full-stack tissue therapeutic platform leverages proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials to create novel cellular medicines capable of replacing or restoring biological function.

Founded in 2013, this Canadian company operates at the intersection of biotechnology and life sciences, advancing a therapeutic pipeline that targets complex endocrine and metabolic diseases, including diabetes and rare endocrine disorders.

In an impressive step forward, Aspect Biosystems secured a significant $79.00M investment in April 2026, backed by Innovation, Science and Economic Development Canada. This endorsement reflects robust institutional trust in their innovative approach and potential to propel the medical frontier toward curative therapies.

Business keywords: Bioprinted Tissue Therapeutics, Cellular Medicines, Regenerative Medicine, AI-Powered Bioprinting, Hypoimmune Cell Engineering, Advanced Biomaterials, Endocrine Diseases, Metabolic Disorders, 3D Bioprinting Technology, Allogeneic Cell Therapy, Organ Function Restoration, Rare Endocrine Disorders, Diabetes Treatment, Tissue Therapeutic Platform, Partnerships in Biotech

Services & Products

Development of Bioprinted Tissue Therapeutics
Regenerative Medicine Solutions
Cutting-edge Biotech Collaborations

Target Customers

Pharmaceutical Companies Biotechnology Firms Healthcare Providers focused on Metabolic and Endocrine Conditions Research Institutions seeking advanced tissue therapies

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Project, Real Estate, Infrastructure Finance $79.00M 1
Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
01 Apr 2026
Series B $115.00M 8
Pangaea Ventures Novo Nordisk Pallasite Ventures
Pangaea Ventures, Novo Nordisk +6
01 Jan 2025
Grant $72.75M 2
Government of Canada Government of British Columbia
Government of Canada, Government of British Columbia
01 Jul 2024
Grant $3.60M -
01 Mar 2023
Round Undisclosed 1
Page One Ventures
Page One Ventures
01 May 2022
Grant $3.68M 1
PacifiCan
01 Jan 2022
Series A $20.00M 13
Pangaea Ventures Hedgewood Pallasite Ventures
Pangaea Ventures, Hedgewood +11
01 Jun 2020
Series A $26.00M 2
Pallasite Ventures Radical Ventures
Pallasite Ventures, Radical Ventures
01 Jan 2020
Grant $2.70M -
01 Nov 2018
Early VC $1.00M 1
Genome British Columbia
01 May 2018

View All 15 Funding Rounds

Aspect Biosystems Alternatives & Competitors

Aspect Biosystems vs
cellvie
cellvie Switzerland

Levearging the therapeutic potential of mitochondria

Seed
11 employees
Biotechnology, Health and Wellness
Aspect Biosystems vs
Rubedo Life Sciences
Rubedo Life Sciences United States

Medicines to keep you biologically young by targeting the pathological cells that drive chronic dise...

Series A
32 employees
Biotechnology, Health Care

FAQ About Aspect Biosystems

Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusive diseases.
Aspect Biosystems was founded in 2013.
Aspect Biosystems is headquartered in Canada.
Aspect Biosystems operates in Biotechnology and Life Sciences. Its work centres on Bioprinted Tissue Therapeutics, Cellular Medicines, Regenerative Medicine and AI-Powered Bioprinting. Its customers include Pharmaceutical Companies, Biotechnology Firms and Healthcare Providers focused on Metabolic and Endocrine Conditions.
Aspect Biosystems has a B2B and Platform business model. Its revenue comes from Licensing, Product Sales and Performance Based.
Aspect Biosystems has approximately 143 employees.
Aspect Biosystems has completed 15 funding rounds, raising a total of $323.73M.
Aspect Biosystems offers: Development of Bioprinted Tissue Therapeutics, Regenerative Medicine Solutions, Cutting-edge Biotech Collaborations.
Top alternatives and competitors to Aspect Biosystems include cellvie, Rubedo Life Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aspect Biosystems and cellvie are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Aspect Biosystems, https://bouncewatch.com/company/aspect-biosystems, updated 26 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes